C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
6.45
+0.84 (14.97%)
At close: Nov 4, 2024, 4:00 PM
6.31
-0.14 (-2.17%)
After-hours: Nov 4, 2024, 7:38 PM EST

C4 Therapeutics Statistics

Total Valuation

CCCC has a market cap or net worth of $455.30 million. The enterprise value is $237.99 million.

Market Cap 455.30M
Enterprise Value 237.99M

Important Dates

The last earnings date was Thursday, October 31, 2024, before market open.

Earnings Date Oct 31, 2024
Ex-Dividend Date n/a

Share Statistics

CCCC has 70.59 million shares outstanding. The number of shares has increased by 31.51% in one year.

Shares Outstanding 70.59M
Shares Change (YoY) +31.51%
Shares Change (QoQ) +1.19%
Owned by Insiders (%) 2.63%
Owned by Institutions (%) 68.47%
Float 47.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 12.36
Forward PS n/a
PB Ratio 1.88
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 7.07
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.31, with a Debt / Equity ratio of 0.28.

Current Ratio 6.31
Quick Ratio 6.14
Debt / Equity 0.28
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -46.00% and return on invested capital (ROIC) is -24.44%.

Return on Equity (ROE) -46.00%
Return on Assets (ROA) -20.61%
Return on Capital (ROIC) -24.44%
Revenue Per Employee $232,193
Profits Per Employee -$727,566
Employee Count 145
Asset Turnover 0.09
Inventory Turnover n/a

Taxes

In the past 12 months, CCCC has paid $277,000 in taxes.

Income Tax 277,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +313.46% in the last 52 weeks. The beta is 3.06, so CCCC's price volatility has been higher than the market average.

Beta (5Y) 3.06
52-Week Price Change +313.46%
50-Day Moving Average 6.01
200-Day Moving Average 6.46
Relative Strength Index (RSI) 58.13
Average Volume (20 Days) 696,299

Short Selling Information

The latest short interest is 6.65 million, so 9.42% of the outstanding shares have been sold short.

Short Interest 6.65M
Short Previous Month 11.01M
Short % of Shares Out 9.42%
Short % of Float 14.04%
Short Ratio (days to cover) 7.48

Income Statement

In the last 12 months, CCCC had revenue of $33.67 million and -$105.50 million in losses. Loss per share was -$1.63.

Revenue 33.67M
Gross Profit -74.85M
Operating Income -116.90M
Pretax Income -106.59M
Net Income -105.50M
EBITDA -115.13M
EBIT -116.90M
Loss Per Share -$1.63
Full Income Statement

Balance Sheet

The company has $255.64 million in cash and $67.10 million in debt, giving a net cash position of $217.31 million or $3.08 per share.

Cash & Cash Equivalents 255.64M
Total Debt 67.10M
Net Cash 217.31M
Net Cash Per Share $3.08
Equity (Book Value) 242.66M
Book Value Per Share 3.44
Working Capital 229.94M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$71.23 million and capital expenditures -$341,000, giving a free cash flow of -$71.58 million.

Operating Cash Flow -71.23M
Capital Expenditures -341,000
Free Cash Flow -71.58M
FCF Per Share -$1.01
Full Cash Flow Statement

Margins

Gross Margin -222.31%
Operating Margin -347.20%
Pretax Margin -312.52%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -268.10%

Dividends & Yields

CCCC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -31.51%
Shareholder Yield -31.51%
Earnings Yield -23.17%
FCF Yield -15.72%

Analyst Forecast

The average price target for CCCC is $10.50, which is 62.79% higher than the current price. The consensus rating is "Buy".

Price Target $10.50
Price Target Difference 62.79%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 176.06%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CCCC has an Altman Z-Score of -0.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.8
Piotroski F-Score 3